2Stratton IMea. Association of glycaemia with macrovascular complication of the type 2 diabetes ( UKPDS 35 ) prospective observa- tional study. Br. Med. J 2000;321:405 -412.
3Khaw K-Tea. Glycated haemoglobin,diabetes,and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br. Med. J 2001 ;322:15 - 18.
4Chan NN, Vallance P, Colhoun HM. Nitric oxide and vascular responses in Type I diabetes. Diabetologia 2000 ;43 : 137 - 147.
5Sowers JR, Lester MA. Diabetes and cardiovascular disease. Diabetes Care 1999 ;22 Suppl 3 :C14 - 20.
6Steiner G. Lipid intervention trials in diabetes. Diabetes Care 2000;23 Suppl 2 :B49 -53.
7Nicholls S J, Tuzcu EM, Kalidindi S, et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008 ;52:255 -262.
8Marso SP, Mercado N, Maehara A, et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with meta- bolic syndrome or diabetes. JACC Cardiovasc Imaging 2012;5: S42 - 52.
9Norhantmar A, Malmberg K, Diderholm E, et al. Diabetes mellitus:the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004 ;43:585 - 591.
10Abizaid A, Costa MA, Centemero M, et al. Clinical and eco- nomic impact of diabetes mellitus on percutaneous and surgical treat- ment of multivessel coronary disease patients :insights from the Arterial Revascularization Therapy Study ( ARTS ) trial. Circulation 2001 ; 104:533 -538.
